Paracrine cyclooxygenase-2-mediated signalling by macrophages promotes tumorigenic progression of intestinal epithelial cells

Oncogene

Volumn 21, Issue 47, 2002, Pages 7175-7186

  Ko, Stanley C W ^a   Chapple, Keith S ^a   Hawcroft, Gillian ^a   Coletta, P Louise ^a   Markham, Alexander F ^a   Hull, Mark A ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Adenomatous polyps; Colorectal cancer; Cyclooxygenase; Macrophage

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA2; UVOMORULIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL INTERACTION; CELL PROLIFERATION; COLON ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; INTESTINE EPITHELIUM CELL; MACROPHAGE; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; RAT; RECTUM ADENOMA; TUMOR GROWTH;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; EPITHELIAL CELLS; INTESTINES; ISOENZYMES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; PARACRINE COMMUNICATION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; RATS; SULFONAMIDES;

ANIMALIA;

EID: 0037126389     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205869     Document Type: Article

References (64)

1. Bamba H, Ota S, Kato A, Adachi A, Itoyama S and Matsuzaki F. (1999). Int. J. Cancer, 83, 470-475.
2. Birchmeier C, Birchmeier W and Brand-Saberi B. (1996). Acta Anat., 156, 217-226.
3. Chapple KS, Cartwright EJ, Hawcroft G, Tisbury A, Bonifer C, Scott N, Windsor AC, Guillou PJ, Markham AF, Coletta PL and Hull MA. (2000). Am. J. Pathol., 156, 545-553.
4. Chulada PC, Thompson MB, Mahler JF, Doyle CM, Gaul BW, Lee C, Tiano HF, Morham SG, Smithies O and Langenbach R. (2000). Cancer Res., 60, 4705-4708.
5. Cordon-Cardo C and Prives C. (1999). J. Exp. Med., 190, 1367-1370.
6. Coussens LM and Werb Z. (2001). J. Exp. Med., 193, F23-F26.
7. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S and DuBois RN. (1994). Gastroenterology, 107, 1183-1188.
8. Farrow DC, Vaughan TL, Hansten PD, Stanford JL, Risch HA, Gammon MD, Chow W-H, Dubrow R, Ahsan H, Mayne ST, Schoenberg JB, West AB, Rotterdam H, Fraumeni JF and Blot WJ, (1998). Cancer Epidemiol. Biomarkers Prev., 7, 97-102.
9. Fu S, Ramanujam KS, Wong A, Fantry GT, Drachenberg CB, James SP, Meltzer SJ and Wilson KT. (1999). Gastroenterology, 116, 1319-1329.
10. Fujita M, Fukui H, Kusaka T, Morita K, Fujii S, Ueda Y, Chiba T, Sakamoto C, Kawamata H and Fujimori T. (2000). J. Gastroenterol. Hepatol., 15, 1277-1281.
11. Gagliardi G, Kandemir O, Liu D, Guida M, Benvestito S, Ruers TG, Benjamin IS, Northover JM, Stamp GW and Talbot IC. (1995). Virchows Archiv., 426, 149-154.
12. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR and Offerhaus GJ. (1993). N. Engl. J. Med., 328, 1313-1316.
13. Giardiello FM, Yang VW, Hylind LM, Krush AJ, Petersen GM, Trimbath JD, Piantadosi S, Garrett E, Geiman DE, Hubbard W, Offerhaus JA and Hamilton SR. (2002). N. Engl. J. Med., 346, 1054-1059.
14. Goldman R and Bar-Shavit Z. (1979), J, Nat. Cancer Inst., 63, 1009-1016.
15. Hardwick JCH, van den Brink GR, Offerhaus GJ, van Deventer SJH and Peppelenbosch MP, (2001). Oncogene, 20, 819-827.
16. Hauptmann S, Zwadlo-Klarwasser G, Jansen M, Klosterhalfen B and Kirkpatrick CJ. (1993). Am. J. Pathol., 143, 1406-1415.
17. Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ and Beach DH, (1999), J. Exp. Med., 190, 1375-1382.
18. Hull MA, Booth JK, Tisbury A, Scott N, Bonifer C, Markham AF and Coletta PL. (1999). Br. J. Cancer, 79, 1399-1405.
19. Hull MA, Fenwick SW, Chapple KS, Scott N, Toogood GJ and Lodge JP. (2000a). Clin. Exp. Metastasis, 18, 21-27.
20. Hull M, Chapple K, Coletta L and Poulsom R, (2000b), Gastroenterology, 119, 600-602.
21. Hwang D, Jang BC, Yu G and Boudreau M. (1997). Biochem. Pharmacol., 54, 87-96.
22. Jacoby RF, Seibert K, Cole CE, Kelloff G and Lubet RA. (2000). Cancer Res., 60, 5040-5044.
23. Khan KNM, Masferrer JL, Woerner BM, Soslow R and Koki AT. (2001). Scand. J. Gastroenterot., 36, 865-869.
24. Kutchera W, Jones DA, Matsunami N, Groden J, McIntyre TM, Zimmerman GA, White RL and Prescott SM. (1996). Proc. Natl. Acad. Sci. USA, 93, 4816-4820.
25. Manning AM, Williams AC, Game SM and Paraskeva C. (1991). Oncogene, 6, 1471-1476.
26. Marx J. (2001). Science, 291, 581-582.
27. Morris CD, Armstrong GR, Bigley G, Green H and Attwood SEA. (2001). Am. J. Gastroenterol., 96, 990-996.
28. Muller-Decker K, Albert C, Lukanov T, Winde G, Marks F and Furstenberger G. (1999). Int. J. Colorectal Dis., 14, 212-218.
29. Mutoh M, Watanabe K, Kitamura T, Shoji Y, Takahashi M, Kawamori T, Tani K, Kobayashi M, Maruyama T, Kobayashi K, Ohuchida S, Sugimoto Y, Narumiya S, Sugimura T and Wakabayashi K. (2002). Cancer Res., 62, 28-32.
30. Nau GJ, Richmond JFL, Schlesinger A, Jennings EG, Lander ES and Young RA. (2002). Proc. Natl. Acad. Sci. USA, 99, 1503-1508.
31. O'Byrne KJ and Dalgleish AG. (2001). Br. J. Cancer, 85, 473-483.
32. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF and Taketo MM. (1996). Cell, 87, 803-809.
33. Oshima M, Mural N, Kargman S, Arguello M, Luk P, Kwong E, Taketo MM and Evans JF. (2000). Cancer Res., 61, 1733-1740.
34. Paraskeva C, Corfield AP, Harper S, Hague A, Audcent K and Williams AC. (1990). Anticancer Res., 10, 1189-1200.
35. Pitot HC, Hikita H, Dragan Y, Sargent L and Haas M. (2000). Aliment. Pharmacol. Therap., 14 (Suppl. 1): S153-S160.
36. Quaroni A, Wands J, Trelstad RL and Isselbacher KJ. (1979). J. Cell Biol., 80, 248-265.
37. Raschke WC, Baird S, Ralph P and Nakoinz I. (1978). Cell, 15, 261-267.
38. Rosenberger CM, Scott MG, Gold MR, Hancock REW and Finlay BB. (2000). J. Immunol., 164, 5894-5904.
39. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M and Hla T. (1999). Cancer Res., 55, 3785-3789.
40. Seno J, Oshima M, Ishikawa T, Oshima H, Takaku K, Chiba T, Narumiya S and Taketo MM. (2002). Cancer Res., 62, 506-511.
41. Sharma RA, Gescher A, Plastaras JP, Leuratti C, Singh R, Gallacher-Horley B, Offord E, Marnett LJ, Steward WP and Plummet SM. (2001). Carcinogenesis, 22, 1557-1560.
42. Shattuck-Brandt RL, Lamps LW, Heppner Goss KJ, DuBois RN and Matrisian LM. (1999). Mol. Carcinog., 24, 177-187.
43. Shattuck-Brandt RL, Varilek GW, Radhika A, Yang F, Washington MK and DuBois RN. (2000). Gastroenterology. 118, 337-345.
44. Sheehan KM, Sheahan K, O'Donoghue DP, MacSweeney F, Conroy RM, Fitzgerald DM and Murray FE. (1999). JAMA, 282, 1254-1257.
45. Sheng GG, Shao J, Sheng H, Hooton EB, Isakson PC, Morrow JD, Coffey RJ, DuBois RN and Beauchamp RD. (1997). Gastroenterology, 113, 1883-1891.
46. Sheng H, Shao J, O'Mahony CA, Lamps L, Albo D, Isakson PC, Berger DH, DuBois RN and Beauchamp RD. (1999). Oncogene, 18, 855-867.
47. Sheng H, Shao J, Washington KM and DuBois RN. (2001). J. Biol. Chem., 276, 18075-18081.
48. Sinicrope FA, Roddey G, McDonnell TJ, Shen Y, Cleary KR and Stephens LC. (1996). Clin. Cancer Res., 2, 1999-2006.
49. Smith M-L, Hawcroft G and Hull MA. (2001). Eur. J. Cancer, 36, 664-674.
50. Sonoshita M, Takaku K, Sasaki N, Sugimoto Y, Ushikubi F, Narumiya S, Oshima M and Taketo MM. (2001). Nature Med., 7, 1048-1051.
51. Soslow RA, Dannenberg AJ, Rush D, Woerner BM, Khan KN, Masferrer J and Koki AT. (2000). Cancer, 89, 2637-2645.
52. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK and Levin B. (2000). N. Engl. J. Med., 342, 1946-1952.
53. Sung JJY, Leung WK, Go MYY, To KF, Cheng ASL, Ng EKW and Chan FKL. (2000). Am. J. Pathol., 157, 729-735.
54. Taketo MM. (1998). Clinical Significance and Potential of Selective COX-2 Inhibitors. Vane JR and Botting RM (eds). London: William Harvey Press, pp. 129-139.
55. Takeuchi M, Kobayashi M, Ajioka Y, Honma T, Suzuki Y, Azumaya M, Narisawa R, Hayashi S and Asakura H. (2002). Int. J. Colorectal Dis., 17, 144-149.
56. Tsujii M and DuBois RN. (1995). Cell, 83, 493-501.
57. Tsujii M, Kawano S and DuBois RN. (1997). Proc. Natl. Acad. Sci. USA, 94, 3336-3340.
58. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M and DuBois RN. (1998). Cell, 93, 705-716.
59. Williams CS, Watson AJ, Sheng H, Helou R, Shao J and DuBois RN. (2000a). Cancer Res., 60, 6045-6051.
60. Williams CS, Tsujii M, Reese J, Dey SK and DuBois RN. (2000b). J. Clin. Invest., 105, 1589-1594.
61. Willson JKV, Bittner GN, Oberley TD, Meisner LF and Weese JL. (1987). Cancer Res., 47, 2704-2713.
62. Wilson KT, Fu S, Ramanujam KS and Meltzer SJ. (1998).. Cancer Res., 58, 2929-2934.
63. Yang VW, Shields JM, Hamilton SR, Spannhake EW, Hubbard WC, Hylind LM, Robinson CR and Giardiello FM. (1998). Cancer Res., 58, 1750-1753.
64. Zhang T, Nanney LB, Peeler MO, Williams CS, Lamps L, Heppner KJ, DuBois RN and Beauchamp RD. (1997). Cancer Res., 57, 1638-1643.